Friedreich ataxia: New findings, new challenges

Annals of Neurology

Volumn 76, Issue 4, 2014, Pages 487-488

  Lynch, David R ^a   Seyer, Lauren ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRIEDREICH ATAXIA; HUMAN;

FRIEDREICH ATAXIA; HUMANS;

EID: 84907811889     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24259     Document Type: Note

References (14)

1. Harding AE. Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 1981;104:589-620.
2. Tsou AY, Paulsen EK, Lagedrost SJ, et al. Mortality in Friedreich ataxia. J Neurol Sci 2011;307:46-49.
3. Campuzano V, Montermini L, Moltò MD, et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996;271:1423-1427.
4. Chutake YK, Lam C, Costello WN, et al. Epigenetic promoter silencing in Friedreich ataxia is dependent on repeat length. Ann Neurol 2014;00:000-000.
5. Friedman LS, Farmer JM, Perlman S, et al. Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Mov Disord 2010;25:426-432.
6. Regner SR, Wilcox NS, Friedman LS, et el. Friedreich ataxia clinical outcome measures: natural history evaluation in 410 participants. J Child Neurol 2012;27:1152-1158.
7. Soragni E, Miao W, Iudicello M, et al. Epigenetic therapy for Friedreich ataxia. Ann Neurol 2014;00:000-000.
8. Plasterer HL, Deutsch EC, Belmonte M, et al. Development of frataxin gene expression measures for the evaluation of experimental treatments in Friedreich's ataxia. PLoS One 2013;8:e63958.
9. Deutsch EC, Santani AB, Perlman SL, et al. A rapid, noninvasive immunoassay for frataxin: utility in assessment of Friedreich ataxia. Mol Genet Metab 2010;101:238-245.
10. Pandolfo M, Arpa J, Delatycki M, et al. Deferiprone in Friedreich ataxia: a six-month controlled trial. Ann Neurol 2014;00:000-000.
11. Pandolfo M. Friedreich ataxia: new pathways. J Child Neurol 2012;27:1204-1211.
12. Boddaert N, Le Quan Sang KH, Rötig A, et al. Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood 2007;110:401-408.
13. EFACTS: European Friedreich Ataxia Consortium for Treatment and Study. Available at: http://www.e-facts.eu/html/studies/home?asgsid57ad987f8067b7f9d3bcc2e7162d12ea6 Accessed August 25, 2014.
14. Lynch DR, Farmer JM, Tsou AY, et al. Measuring Friedreich ataxia: complementary features of examination and performance measures. Neurology 2006;66:1711-1716.